A randomized controlled clinical trial: Interruption of intrauterine transmission of hepatitis B virus infection with HBIG

Table 1 Comparision of cord blood: HBeAg and HBV-DNA positive rate

Groups	cases	HBeAg(+)		HBV- DNA(+)
		n	%	n	%
Trial	28	6	21.4	7	25
Control	24	19	79.2	20	83.3

Table 2 HBV-DNA levels in 7 mother-infant pairs in trial group (gene copy/mL)

Pair No.	Pregnant women	Filial generation
1	1.16 × 108	1.88 × 105
2	4.45 × 108	2.84 × 104
3	2.74 × 108	1.83 × 105
4	4.78 × 107	3.56 × 105
5	1.53 × 108	2.66 × 105
6	3.94 × 108	2.92 × 104
7	2.28 × 108	1.68 × 105